Skip to main content

Animations

MJFF Publications

4551 - 4560 of 9148 Results
Title
Year
  • Year
  • 2020
  • 2021
  • 2016
  • 2011
  • 2013
  • 2019
  • 2021
  • 2024
  • 2024
  • 2021
  • Summary Details
    OPEN
    Title: “I Want to Do It, But I Want to Make Sure That I Do It Right.” Views of Patients with Parkinson’s Disease Regarding Early Stem Cell Clinical Trial Participation
    Journal Name: AJOB Empirical Bioethics
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1080/23294515.2020.1775721
    Citation Count: 6
  • Dysregulated miRNAs mark Parkinson’s disease progression
    2021
    Summary Details
    RESTRICTED
    Title: Dysregulated miRNAs mark Parkinson’s disease progression
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s43587-021-00046-2
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Perspective: Data sharing for discovery
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/538s4a
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Panels, Mini-Panels and Study Groups
    Journal Name: Neuropsychopharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/npp.2011.290
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Parkinson's Disease Biomarkers: Resources for Discovery and Validation
    Journal Name: Neuropsychopharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/npp.2013.246
    Citation Count: 6
  • Summary Details
    OPEN
    Title: α‐Synuclein in blood cells differentiates Parkinson’s disease from healthy controls
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/acn3.50944
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Lack of progression of beta dynamics after long‐term subthalamic neurostimulation
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/acn3.51463
    Citation Count: 33
  • Summary Details
    OPEN
    Title: Reduced striatal M4-cholinergic signaling following dopamine loss contributes to parkinsonian and l -DOPA–induced dyskinetic behaviors
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adp6301
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Florbetaben amyloid PET acquisition time: Influence on Centiloids and interpretation
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/alz.13893
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Dystonia Responsive to Dopamine: POLG Mutations Should Be Considered If Sensory Neuropathy Is Present
    Journal Name: Journal of Movement Disorders
    Publisher: The Korean Movement Disorder Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.14802/jmd.20159
    Citation Count: 11
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.